Industry Sessions

13:15 – 14:15, Room 13A

Industry Satellite Symposia

From prevention to acute stroke: advances across stroke pathways

Chairperson: Hanno Herrmann

13:15 – 13:25, Lowering the global burden of stroke” – Siemens Healthineers’ strategy to optimize stroke treatment and prevent recurrences, Hanno Herrmann

13:25 – 13:35, From prevention to acute stroke: current challenges, Pieter Jan van Doormaal

13:35 – 13:50, NAEOTOM Alpha: increased diagnostic performances with photon-counting CT technology, Pieter Jan van Doormaal

13:50 – 14:05, How ARTIS icono helps in treatment and prevention of hemmorhagic stroke, Markus Holtmannspötter

14:05 – 14:15, Q&A, Hanno Herrmann, Pieter Jan van Doormaal, Markus Holtmannspötter

13:15 – 14:15, Room 13B

Industry Satellite Symposia

Evidence-based therapies for all stroke patients – advances and guideline recommendations

Chairperson: Ales Tomek

13:15 – 13:30, Introduction, Ales Tomek

13:30 – 13:50, Get with the guidelines in post stroke motor recovery, Steven Zeiler

13:50 – 14:15, Effective Cerebroprotection in the stroke reperfusion era – why we need it?, Jacek Staszewski

13:15 – 14:15, Room 4

Industry Satellite Symposia

Stroke Care Optimization Driven by Real World Evidence

Chairperson: Raul Nogueira

13:15 – 13:30, The Andalucian Stroke Network Experience, Joan Montaner

13:30 – 13:45, Brainomix in the Real World: Reflections & Learning on e-Stroke, Kiruba Nagaratnam

13:45 – 14:00, Health Economic Benefits of Mechanical Thrombectomy, Manu Moreu

14:00 – 14:15, Building a Regional Thrombectomy Network with e-Stroke, Alex Szolics

13:15 – 14:45, Room 13A

Industry Satellite Symposia

Population Awareness – The Final Frontier

Chairperson: Simona Sacco

13:15 – 13:30, Speaking To Stroke Patients: Understanding What Our Patients Do Before They Arrive At The Hospital, Hong Chuan Loh

13:30 – 13:50, Fast Heroes – On A Grand Mission To Save Our Grandparents, Sheila Martins

13:50 – 14:10, 250,000 Families Say It Works!, Jan van der Merwe

14:10 – 14:30, How Your Hospital Can Get Involved, Sandra Martins, Catarina Maria Frias Rodrigues

14:10 – 14:30, World Health Organization: Implementing Fast Heroes In Kyrgysztan, Aliina Altymysheva

13:15 – 14:15, Room 13B

Industry Satellite Symposia

Customized Stroke Management: Embracing Personalized Care and Latest Technologies

Chairperson: Luca Callegari

13:15 – 13:35, AF Screening in Cryptogenic Stroke – monitoring strategies and patient selection, Danilo Toni

13:35 – 13:55, Early procedural experience with the Solitaire 3mm MeVO device, Markus Möhlenbruch

13:55 – 14:15, Rationale behind MeVO treatments, Urs Fischer

13:15 – 14:45, Room 5

Industry Satellite Symposia

Real-World Data and the Management of ICH in Anticoagulated Patients

Chairperson: W. Brian Gibler

13:15 – 13:20, Welcome, Introductions, and Symposium Pre-Test, W. Brian Gibler

13:20 – 13:28, Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience, Natalie Kreitzer

13:28 – 13:35, Case Presentation: Management of a Patient With Vitamin K Antagonist-Associated Intracranial Hemorrhage (ICH), Natalie Kreitzer13:35 – 13:45, Roundtable Discussion: Repletion Management for Vitamin K Antagonist Anticoagulation, All: W. Brian Gibler, Natalie Kreitzer, David Seiffge, Adrian Parry-Jones

13:45 – 13:53, Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence, David Seiffge

13:53 – 14:00, Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy, David Seiffge

14:00 – 14:10, Roundtable Discussion: Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding, All: W. Brian Gibler, Natalie Kreitzer, David Seiffge, Adrian Parry-Jones

14:10 – 14:18, Development of a Critical Care Pathway for Patients With ICH Using Specific Reversal Agents for Anticoagulated Patients With ICH, Adrian Parry-Jones

14:18 – 14:25, Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy – Importance of Timing, Adrian Parry-Jones

14:45, Roundtable Discussion, Post-Test, and Audience Q & A – Reinforcement of Principles and Overcoming Treatment Barriers, All: W. Brian Gibler, Natalie Kreitzer, David Seiffge, Adrian Parry-Jones

13:15 – 14:45, Room 2

Industry Satellite Symposia

Factor XI(a) Inhibition: A New Approach in Secondary Stroke Prevention and Patient Protection?

Chairperson: Valeria Caso

13:15 – 13:20, Welcome and Introductions, Valeria Caso

13:20 – 13:30, Epidemiology of Stroke and Burden of Disease, Valeria Caso

13:30 – 13:40, Current Approaches in Antithrombotic Therapy, Martin Dichgans

13:40 – 13:50, Unmet Medical Need, Mike Sharma

13:50 – 14:05, Evolution of FXIa as a Target and Mechanism of Action, John Eikelboom

14:05 – 14:20, Existing Clinical Studies in FXIa Inhibition for Secondary Stroke Prevention, Ashkan Shoamanesh

14:20 – 14:40, Panel Discussion and Q&A, All: Valeria Caso, Martin Dichgans, Mike Sharma, John Eikelboom, Ashkan Shoamanesh

14:40 – 14:45 Closing Remarks, Mike Sharma

14:15 – 14:45, Room 11

Industry Meet The Expert Session

Anticoagulation for AF patients with stroke: an update from guidelines and clinical practice

Chairperson: Rónán Collins

14:15 – 14:17, Welcome and introduction, Rónán Collins

14:17 – 14:25, Spotlight on latest guideline recommendations: a perspective on anticoagulation after stroke, Rónán Collins

14:25 – 14:33, Insights from real-world evidence: anticoagulation for AF stroke patients in clinical routine, Paolo Profice

14:33 – 14:43, Q&A session and panel discussion, All: Rónán Collins, Paolo Profice

14:43 – 14:45, Summary and conclusion, Rónán Collins

14:15 – 14:45, Room 4

Industry Meet The Expert Session

A case-based debate: which of your patients might benefit from left atrial appendage occlusion?

Chairperson: Peter Rothwell

Debate session, Panel: Hans Christoph Diener, Marta Rubiera del Fueyo

Moderator: Peter Rothwell